Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells
Blood (2006) 108 (13): 4071–4077.
Currently there are no citedby results. Try again later.
